126 related articles for article (PubMed ID: 2632999)
1. Sensitivity of yeasts to amphotericin B and 5-fluorocytosine.
Abdul-Samad S; Arumugham G; Yasin MS
Malays J Pathol; 1989 Aug; 11():37-42. PubMed ID: 2632999
[TBL] [Abstract][Full Text] [Related]
2. [Comparative sensitivity of yeasts to antifungal agents using a standardized micromethod].
Guinet R
Pathol Biol (Paris); 1986 May; 34(5):536-9. PubMed ID: 3534739
[TBL] [Abstract][Full Text] [Related]
3. [In vitro sensitivity to 5-fluorocytosine and amphotericin B of yeasts of the Candida genus isolated in Barcelona].
Torres-Rodríguez JM; Sabaté M; Gallach C; Carrillo A; Madrenys N
Enferm Infecc Microbiol Clin; 1990 Feb; 8(2):91-3. PubMed ID: 2098147
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents.
Favel A; Michel-Nguyen A; Datry A; Challier S; Leclerc F; Chastin C; Fallague K; Regli P
J Antimicrob Chemother; 2004 Mar; 53(3):526-9. PubMed ID: 14963064
[TBL] [Abstract][Full Text] [Related]
5. Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest.
Chiu YS; Chang SC; Hsueh PR; Wang JL; Sun HY; Chen YC
J Microbiol Immunol Infect; 2006 Aug; 39(4):335-41. PubMed ID: 16926981
[TBL] [Abstract][Full Text] [Related]
6. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts.
Quindós G; Ruesga MT; Martín-Mazuelos E; Salesa R; Alonso-Vargas R; Carrillo-Muñoz AJ; Brena S; San Millán R; Pontón J
Rev Iberoam Micol; 2004 Jun; 21(2):63-9. PubMed ID: 15538829
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
Paniagua GL; Monroy E; Negrete E; Vaca S
Rev Latinoam Microbiol; 2002; 44(2):65-8. PubMed ID: 17063773
[TBL] [Abstract][Full Text] [Related]
8. [Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].
Fujita S
Rinsho Byori; 1996 Apr; 44(4):373-8. PubMed ID: 8847821
[TBL] [Abstract][Full Text] [Related]
9. Relationship between in vitro activities of amphotericin B and flucytosine and pH for clinical yeast and mold isolates.
te Dorsthorst DT; Verweij PE; Meis JF; Mouton JW
Antimicrob Agents Chemother; 2005 Aug; 49(8):3341-6. PubMed ID: 16048945
[TBL] [Abstract][Full Text] [Related]
10. Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
Linares MJ; Muñoz JF; Solís F; Rodríguez FC; Valero A; Casal M
Rev Esp Quimioter; 1998 Mar; 11(1):64-9. PubMed ID: 9795292
[TBL] [Abstract][Full Text] [Related]
11. [Antifungal susceptibility of yeasts by Etest. Comparison of 3 media].
Tapia C; León E; Palavecino E
Rev Med Chil; 2003 Mar; 131(3):299-302. PubMed ID: 12790079
[TBL] [Abstract][Full Text] [Related]
12. [Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing].
Yamane N; Igari J
Rinsho Byori; 1997 Feb; 45(2):190-9. PubMed ID: 9121005
[TBL] [Abstract][Full Text] [Related]
13. [Determination of the in vitro antifungal susceptibility of clinically important yeasts using the Sensititre system].
Carrillo-Muñoz AJ; Quindós G; Gasser I; Tur-Tur C; Ruesga MT; Alonso-Vargas R; Arévalo P; Bornay-Llinares FJ; Santos P; del Valle O
Rev Esp Quimioter; 1999 Jun; 12(2):126-35. PubMed ID: 10562673
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period.
Kucukates E; Erturan Z; Susever S; Yegenoglu Y
APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species.
Moore CB; Oakley KL; Denning DW
Clin Microbiol Infect; 2001 Jan; 7(1):11-6. PubMed ID: 11284937
[TBL] [Abstract][Full Text] [Related]
16. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
Park BJ; Park JC; Taguchi H; Fukushima K; Hyon SH; Takatori K
Biochem Biophys Res Commun; 2006 Aug; 347(2):401-5. PubMed ID: 16831406
[TBL] [Abstract][Full Text] [Related]
17. [In vitro sensitivity tests for yeasts: evaluation of a micromethod].
Rodero LL; Davel GO; Vivot W; Canteros CE; Fernández C
Rev Argent Microbiol; 1995; 27(2):81-9. PubMed ID: 8552761
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates.
Lynch ME; Sobel JD
J Med Vet Mycol; 1994; 32(4):267-74. PubMed ID: 7983571
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of candida isolates from denture-related stomatitis to antifungal agents in vitro.
Dorocka-Bobkowska B; Konopka K
Int J Prosthodont; 2007; 20(5):504-6. PubMed ID: 17944341
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B.
Singh J; Rimek D; Kappe R
Mycoses; 2006 Mar; 49(2):96-103. PubMed ID: 16466441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
